Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 861317
                    [Title] => SEC’s revised Code of Corporate Governance
                    [Summary] => 
The Center for Global Best Practices (CGBP) is holding a special seminar entitled “SEC’s Revised Code of Corporate Governance” scheduled on November 27, 2012 at Edsa Shangri-La, Mandaluyong City.

                    [DatePublished] => 2012-10-29 00:00:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Business
                    [SectionUrl] => business
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 841594
                    [Title] => Bristol-Myers ends hepatitis C drug development
                    [Summary] => 
Drugmaker Bristol-Myers Squibb Co. has scrapped a potential hepatitis C treatment after a patient participating in a test of the drug died of heart failure.

 
                    [DatePublished] => 2012-08-24 08:24:23
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => 
                    [SectionUrl] => 
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 513824
                    [Title] => Seminar on SEC's Revised Code set
                    [Summary] => 
The Center for Global Best Practices (CGBP) is holding a special seminar titled SEC’s Revised Code of Corporate Governance’ on Nov. 13 at Edsa Shangri-La, Mandaluyong City.
                    [DatePublished] => 2009-10-15 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Business
                    [SectionUrl] => business
                    [URL] => 
                )

            [3] => Array
                (
                    [ArticleID] => 512956
                    [Title] => Corporate governance seminar set
                    [Summary] => 
The Center for Global Best Practices (CGBP) is holding a special seminar entitled “SEC’s Revised Code of Corporate Governance” on Nov. 13 at the Edsa Shangri-La, Mandaluyong City.
                    [DatePublished] => 2009-10-12 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Business
                    [SectionUrl] => business
                    [URL] => 
                )

        )

)

BRISTOL MYERS

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 861317
                    [Title] => SEC’s revised Code of Corporate Governance
                    [Summary] => 
The Center for Global Best Practices (CGBP) is holding a special seminar entitled “SEC’s Revised Code of Corporate Governance” scheduled on November 27, 2012 at Edsa Shangri-La, Mandaluyong City.

                    [DatePublished] => 2012-10-29 00:00:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Business
                    [SectionUrl] => business
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 841594
                    [Title] => Bristol-Myers ends hepatitis C drug development
                    [Summary] => 
Drugmaker Bristol-Myers Squibb Co. has scrapped a potential hepatitis C treatment after a patient participating in a test of the drug died of heart failure.

 
                    [DatePublished] => 2012-08-24 08:24:23
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => 
                    [SectionUrl] => 
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 513824
                    [Title] => Seminar on SEC's Revised Code set
                    [Summary] => 
The Center for Global Best Practices (CGBP) is holding a special seminar titled SEC’s Revised Code of Corporate Governance’ on Nov. 13 at Edsa Shangri-La, Mandaluyong City.
                    [DatePublished] => 2009-10-15 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Business
                    [SectionUrl] => business
                    [URL] => 
                )

            [3] => Array
                (
                    [ArticleID] => 512956
                    [Title] => Corporate governance seminar set
                    [Summary] => 
The Center for Global Best Practices (CGBP) is holding a special seminar entitled “SEC’s Revised Code of Corporate Governance” on Nov. 13 at the Edsa Shangri-La, Mandaluyong City.
                    [DatePublished] => 2009-10-12 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Business
                    [SectionUrl] => business
                    [URL] => 
                )

        )

)

abtest

SEC’s revised Code of Corporate Governance

October 29, 2012 - 12:00am

The Center for Global Best Practices (CGBP) is holding a special seminar entitled “SEC’s Revised Code of Corporate Governance” scheduled on November 27, 2012 at Edsa Shangri-La, Mandaluyong Ci...

Business

Bristol-Myers ends hepatitis C drug development

August 24, 2012 - 8:24am

Drugmaker Bristol-Myers Squibb Co. has scrapped a potential hepatitis C treatment after a patient participating in a test of the drug died of heart failure.  

Seminar on SEC's Revised Code set

October 15, 2009 - 12:00am

The Center for Global Best Practices (CGBP) is holding a special seminar titled SEC’s Revised Code of Corporate Governance’ on Nov. 13 at Edsa Shangri-La, Mandaluyong City.

Business

Corporate governance seminar set

October 12, 2009 - 12:00am

The Center for Global Best Practices (CGBP) is holding a special seminar entitled “SEC’s Revised Code of Corporate Governance” on Nov. 13 at the Edsa Shangri-La, Mandaluyong City.

Business